Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
Bristol-Myers Squibb(BMY) stock is priced at $56.68, giving the company a market capitalization of 115.77B. It carries a P/E multiple of 15.83 and pays a dividend yield of 4.4%.
During the trading session on 2026-05-14, Bristol-Myers Squibb(BMY) shares reached a daily high of $57.05 and a low of $56.10. At a current price of $56.68, the stock is +1.0% higher than the low and still -0.6% under the high.
Trading activity shows a volume of 4.64M, compared to an average daily volume of 12.06M.
The stock's 52-week range extends from a low of $42.52 to a high of $62.89.
The stock's 52-week range extends from a low of $42.52 to a high of $62.89.
BMY News
Bristol Myers Squibb (NYSE:BMY) announced a global collaboration and licensing deal with Hengrui Pharma valued at up to $15.2 billion. The agreement covers joi...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter,...
Analyst ratings
58%
of 31 ratingsMore BMY News
Advertisement Why Bristol-Myers Squibb (BMY) is on investors’ radar Bristol-Myers Squibb (BMY) has drawn fresh attention after recent trading left the stock d...
Bristol-Myers Squibb Co. (NYSE:BMY) on Tuesday announced a partnership with Hengrui Pharma to develop a portfolio of 13 early-stage programs spanning oncology,...
Bristol-Myers Squibb has struck a strategic partnership and licensing deal with major Chinese drugmaker Hengrui Pharmaceuticals. Dado Ruvic / Reuters U.S. phar...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Bristol-Myers Squibb (BMY) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5%...
European Commission approves Sotyktu (deucravacitinib) for adults with active psoriatic arthritis. First TYK2 inhibitor cleared for this indication in the Euro...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.